{"id":"NCT01277211","sponsor":"Organon and Co","briefTitle":"A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)","officialTitle":"A Randomized, Open-Label, Controlled, Multi-Center Trial to Evaluate the Contraceptive Efficacy, Cycle Control, Safety and Acceptability of NuvaRing® (SCH 900702) in Chinese Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-19","primaryCompletion":"2013-09-18","completion":"2013-09-18","firstPosted":"2011-01-14","resultsPosted":"2014-09-15","lastUpdate":"2024-06-20"},"enrollment":983,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"ENG 120 µg + EE 15 µg intravaginal ring","otherNames":["NuvaRing"]},{"type":"DRUG","name":"DRSP 3 mg + EE 30 µg","otherNames":["Yasmin"]}],"arms":[{"label":"ENG-EE (NuvaRing)","type":"EXPERIMENTAL"},{"label":"DRSP-EE","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to assess the effectiveness of NuvaRing® (SCH 900702) for the prevention of pregnancy in fertile Chinese women. The acceptability and safety of NuvaRing® will also be assessed and compared with that of Yasmin.","primaryOutcome":{"measure":"Pearl Index, by Treatment Group","timeFrame":"Up to 1 year","effectByArm":[{"arm":"ENG-EE (NuvaRing)","deltaMin":1.92,"sd":null},{"arm":"DRSP-EE","deltaMin":3.12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.531"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27339759"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":714},"commonTop":[]}}